197 related articles for article (PubMed ID: 34744456)
21. Prognostic prediction and gene regulation network of
Ji P; Wang H; Cheng Y; Liang S
J Gastrointest Oncol; 2021 Dec; 12(6):3061-3078. PubMed ID: 35070430
[TBL] [Abstract][Full Text] [Related]
22. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of
Lin T; Zhang E; Lin Z; Peng L
Int J Gen Med; 2021; 14():9117-9130. PubMed ID: 34876845
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer.
Yuan W; Xie S; Wang M; Pan S; Huang X; Xiong M; Xiao RJ; Xiong J; Zhang QP; Shao L
Onco Targets Ther; 2018; 11():1683-1695. PubMed ID: 29615843
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
26. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
27. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
28. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
Cai X; Zhou J; Deng J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
[TBL] [Abstract][Full Text] [Related]
29. High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.
Wei Z; Duan X; Li Q; Li Q; Wang Y
J Gastrointest Oncol; 2021 Dec; 12(6):2966-2984. PubMed ID: 35070423
[TBL] [Abstract][Full Text] [Related]
30. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
31. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
32. CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
He K; Xie M; Li J; He Y; Yin Y
Int J Gen Med; 2022; 15():7493-7510. PubMed ID: 36187159
[TBL] [Abstract][Full Text] [Related]
33. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma.
Yu DC; Chen XY; Li X; Zhou HY; Yu DQ; Yu XL; Hu YC; Zhang RH; Zhang XB; Zhang K; An JD
Sci Rep; 2021 May; 11(1):11165. PubMed ID: 34045512
[TBL] [Abstract][Full Text] [Related]
34.
Tan Z; Chen M; Peng F; Yang P; Peng Z; Zhang Z; Li X; Zhu X; Zhang L; Zhao Y; Liu Y
Transl Cancer Res; 2022 Aug; 11(8):2713-2732. PubMed ID: 36093522
[TBL] [Abstract][Full Text] [Related]
35. CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma.
Tian Y; Han W; Fu L; Lv K; Wu S
Biotechnol Genet Eng Rev; 2023 May; ():1-17. PubMed ID: 37248764
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma.
Yu B; Liang H; Ye Q; Wang Y
J Gastrointest Oncol; 2020 Oct; 11(5):1009-1023. PubMed ID: 33209494
[TBL] [Abstract][Full Text] [Related]
37. High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
Zheng LL; Wang YR; Liu ZR; Wang ZH; Tao CC; Xiao YG; Zhang K; Wu AK; Li HY; Wu JX; Xiao T; Rong WQ
World J Gastrointest Surg; 2023 Aug; 15(8):1600-1614. PubMed ID: 37701707
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma.
Fu B; Zhou M; Song G; Zeng H; Gong Y; Jiang Y; Ke Y; Huang D; Peng H; Li Q
Aging (Albany NY); 2023 Apr; 15(7):2734-2771. PubMed ID: 37059591
[TBL] [Abstract][Full Text] [Related]
39. Spindle and Kinetochore-associated Family Genes are Prognostic and Predictive Biomarkers in Hepatocellular Carcinoma.
Cai C; Zhang Y; Hu X; Yang S; Ye J; Wei Z; Chu T
J Clin Transl Hepatol; 2022 Aug; 10(4):627-641. PubMed ID: 36062274
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of TPM1-4 in hepatocellular carcinoma.
Tian Z; Zhao J; Wang Y
Cancer Med; 2022 Jan; 11(2):433-446. PubMed ID: 34850589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
